San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem ...

La preeclampsia (PE) es una complicación del embarazo, caracterizada por hipertensión arterial y función renal anormal, que afecta entre el 5 y el 8 % de todos los embarazos. Es responsable de una ...

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...

CIRM’s Education and Training programs are a vital link to tomorrow. The California Institute for Regenerative Medicine (CIRM) offers invaluable educational and training pathways in regenerative ...

At the heart of our outreach are strong community partnerships, built on trusted relationships with local leaders who engage directly with community members and connect groundbreaking research to the ...

CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...

CIRM is dedicated to accelerating the development of cell and gene therapies and making them accessible to Californians who need them. Our goal is to shape a more inclusive and equitable regenerative ...

The Alpha Clinics Network is pursuing its goal to accelerate the development and delivery of stem cell treatments to patients through high quality clinical trials. Browse the list of ongoing trials at ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

HIV, or the human immunodeficiency virus, is a virus that infects cells of the immune system, undermining the body’s ability to fight infection and disease. Eventually infection can lead to symptoms ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.